China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)

China · Delayed Price · Currency is CNY

17.47

-0.38 (-2.13%)

May 12, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biochemical Pharmaceutical Product	181.66M	211.84M	335.11M	-	510.94M
Biochemical Pharmaceutical Product Growth	-14.25%	-36.78%	-	-	-19.47%
Blood Products Business	1.67B	1.51B	1.45B	-	1.23B
Blood Products Business Growth	10.42%	4.32%	-	-	34.96%
Offset of Business Segment	-1.14M	-	-	-	-23.72M
Other Business	8.49M	10.17M	9.94M	-	29.77M
Other Business Growth	-16.51%	2.32%	-	-	14.84%
Pharmaceutical Distribution Business	197.91M	2.02M	757.80M	-	663.63M
Pharmaceutical Distribution Business Growth	9708.34%	-99.73%	-	-	3.74%
Diabetes Medicine Business	-	-	97.44M	-	237.89M
Diabetes Medicine Business Growth	-	-	-	-	-25.72%
Total	2.06B	1.74B	2.65B	-	2.65B
Total Growth	18.44%	-34.45%	-	-	5.47%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China	2.06B	1.73B	2.65B	2.76B	2.65B
Mainland China Growth	18.69%	-34.58%	-3.87%	4.08%	5.47%
Total	2.06B	1.73B	2.65B	2.76B	2.65B
Total Growth	18.69%	-34.58%	-3.87%	4.08%	5.47%

Source: S&P Global Market Intelligence.